Guidelines for the management of dyspepsia (Q34453424)

2 August 2017

Guidelines for the management of dyspepsia. (English)

1 reference

2 August 2017

1

Nicholas J Talley

1 reference

2 August 2017

Nimish Vakil

2

1 reference

PubMed ID

16181387

2 August 2017

Practice Parameters Committee of the American College of Gastroenterology

series ordinal

3

1 reference

PubMed ID

16181387

2 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

The American Journal of Gastroenterology

2 August 2017

1 reference

2 August 2017

100

1 reference

2 August 2017

10

1 reference

2 August 2017

2324-2337

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

2 August 2017

1 reference

The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Identifying patients with gastroesophageal reflux disease: validation of a practical screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

One-year prognosis of primary care dyspepsia: predictive value of symptom pattern, Helicobacter pylori and GP management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Antro-fundic dysfunctions in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

The proximal stomach and postprandial symptoms in functional dyspeptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992-1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Dyspepsia management in primary care: a decision analysis of competing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Approach to treatment of dyspepsia in primary care: a randomized trial comparing "test-and-treat" with prompt endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

The stool antigen test for detection of Helicobacter pylori after eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Blood, urine, stool, breath, money, and Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Seven-day therapy for Helicobacter pylori in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Review article: Helicobacter pylori and reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Review Article: is Helicobacter pylori relevant in the management of reflux disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Early events in proton pump inhibitor-associated exacerbation of corpus gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Yield of endoscopy in dyspepsia and concurrent treatment with proton pump inhibitors: the blind leading the blind?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Dyspepsia in primary care: acid suppression as effective as prokinetic therapy. A randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Therapeutic options in nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

The treatment of functional dyspepsia with red pepper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Chronic abdominal wall pain: a frequently overlooked problem. Practical approach to diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Pathophysiology as a basis for understanding symptom complexes and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Predominant symptoms identify different subgroups in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00225.X

Psychological interventions for non-ulcer dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002301.PUB4

Identifiers

DOI

10.1111/J.1572-0241.2005.00225.X

1 reference

2 August 2017

1 reference

PubMed ID

16181387